Tiziana Management Team to Attend the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto
Tiziana Life Sciences announced management and business development staff will attend the joint ACTRIMS-ECTRIMS meeting (MSToronto2026) in Toronto, October 21-23, 2026. The company will discuss its clinical programs, including the INFORM-MS Phase 2a trial (NCT06292923) of intranasal foralumab in non-active secondary progressive multiple sclerosis, plus studies in Alzheimer's, MSA, and ALS.
Key figures
- Conference name
- MSToronto2026 (10th Joint ACTRIMS-ECTRIMS Meeting)
- Conference dates
- October 21-23, 2026
- Expanded access patients dosed
- 14
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.